Asian Journal of Pharmaceutical Sciences

Scope & Guideline

Pioneering research at the forefront of pharmaceutical innovation.

Introduction

Welcome to your portal for understanding Asian Journal of Pharmaceutical Sciences, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1818-0876
PublisherSHENYANG PHARMACEUTICAL UNIV
Support Open AccessYes
CountryChina
TypeJournal
Convergefrom 2009 to 2024
AbbreviationASIAN J PHARM SCI / Asian J. Pharm. Sci.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSHENYANG PHARMACEUTICAL UNIV, NO 103, WENHUA RD, SHENYANG 110016, PEOPLES R CHINA

Aims and Scopes

The Asian Journal of Pharmaceutical Sciences focuses on advancing research in pharmaceutical sciences with a strong emphasis on innovative drug delivery systems, nanotechnology applications, and therapeutic strategies. The journal aims to bridge the gap between fundamental research and clinical applications, fostering interdisciplinary approaches to address current challenges in drug development and therapy.
  1. Innovative Drug Delivery Systems:
    The journal emphasizes the development of novel drug delivery systems, including nanocarriers, hydrogels, and microneedles, to enhance the bioavailability and efficacy of therapeutic agents.
  2. Nanotechnology in Medicine:
    A significant focus is placed on the application of nanotechnology in medicine, particularly in creating nanoparticles for targeted therapy, imaging, and diagnostics, thus improving treatment outcomes.
  3. Therapeutic Strategies for Chronic Diseases:
    Research addressing therapeutic strategies for chronic diseases, including cancer, diabetes, and inflammatory conditions, is a core area, with an emphasis on personalized medicine and combination therapies.
  4. Biomaterials and Regenerative Medicine:
    The journal covers advancements in biomaterials and their applications in tissue engineering and regenerative medicine, exploring their potential in drug delivery and wound healing.
  5. Extracellular Vesicles and Stem Cell Applications:
    There is a growing interest in the use of extracellular vesicles and stem cells for therapeutic applications, particularly in the context of regenerative medicine and targeted drug delivery.
Recent publications in the Asian Journal of Pharmaceutical Sciences indicate a clear trend towards innovative therapeutic strategies and advanced drug delivery systems. These emerging themes reflect the journal's commitment to addressing contemporary challenges in pharmaceutical sciences.
  1. Nanomedicine and Targeted Therapy:
    A significant increase in research focused on nanomedicine and targeted therapeutic strategies highlights the journal's direction towards improving drug efficacy and minimizing side effects through precision medicine.
  2. Smart Drug Delivery Systems:
    Emerging themes around smart and stimuli-responsive drug delivery systems are gaining traction, showcasing advancements in technology that allow for controlled and on-demand release of therapeutics.
  3. Immunotherapy and Cancer Treatment:
    There is a notable rise in publications addressing immunotherapy, particularly in cancer treatment, reflecting a shift towards harnessing the body's immune system to combat malignancies.
  4. Regenerative Medicine and Tissue Engineering:
    Research on regenerative medicine and the use of biomaterials for tissue engineering is increasingly prominent, indicating a growing interest in developing solutions for complex tissue repair and regeneration.
  5. Gene Therapy and CRISPR Technologies:
    The exploration of gene therapy approaches, including CRISPR technologies, is becoming more prevalent, reflecting the journal's focus on innovative techniques to address genetic disorders and enhance therapeutic outcomes.

Declining or Waning

While the Asian Journal of Pharmaceutical Sciences continues to explore a wide range of topics, certain themes appear to be declining in prominence over recent years. This shift may reflect broader trends in the field or a response to emerging research priorities.
  1. Traditional Pharmaceutical Formulations:
    Research focusing on conventional pharmaceutical formulations, such as tablets and capsules, is becoming less prominent as newer, more innovative drug delivery systems gain attention.
  2. Basic Pharmacology Studies:
    Studies that primarily focus on basic pharmacological mechanisms without a strong translational aspect are waning, as the journal shifts towards more applied research with direct clinical relevance.
  3. In vitro Drug Testing Models:
    There is a noticeable decline in papers utilizing traditional in vitro drug testing models, as researchers increasingly favor more complex, relevant models that better mimic in vivo conditions.
  4. Nutraceuticals and Herbal Medicine:
    While still relevant, the emphasis on nutraceuticals and herbal medicines seems to be decreasing, possibly due to a growing focus on synthetic and biopharmaceuticals in therapeutic research.
  5. Single-Drug Therapies:
    The focus on single-drug therapies is diminishing as combination therapies and multi-target approaches become more favored in treating complex diseases.

Similar Journals

Asian Journal of Pharmaceutical Research and Health Care

Exploring New Frontiers in Health and Pharmacology
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2250-1444Frequency: 4 issues/year

Asian Journal of Pharmaceutical Research and Health Care, published by Wolters Kluwer Medknow Publications, serves as a vital platform for disseminating cutting-edge research in the fields of pharmacology, toxicology, and healthcare. With an ISSN of 2250-1444 and an E-ISSN of 2250-1460, this journal aims to provide valuable insights and advancements in pharmaceutical sciences, targeting researchers, practitioners, and students dedicated to improving health outcomes. Although its coverage in Scopus was discontinued in 2016, the journal maintains importance within the academic community by fostering discourse and sharing knowledge on emerging topics. Despite its challenges reflected in the low Scopus ranking within its category, the Asian Journal of Pharmaceutical Research and Health Care remains committed to enhancing access to critical research and publishing high-quality work that bridges the gap between theory and practice in health care. Researchers and professionals engaged in the pharmaceutical field are encouraged to contribute and leverage this journal as a means to advance their work and elevate healthcare standards in Asia and beyond.

Journal of Pharmaceutical Health Care and Sciences

Bridging disciplines to elevate pharmaceutical practices.
Publisher: BMCISSN: 2055-0294Frequency: 1 issue/year

The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.

Theranostics

Innovative Insights for Enhanced Patient Care.
Publisher: IVYSPRING INT PUBLISSN: 1838-7640Frequency: 1 issue/year

Theranostics is a premier journal in the field of Medicine and Pharmacology, published by IVYSPRING INT PUBL. With its commitment to open access since 2011, it facilitates the widespread dissemination of innovative research, fostering collaboration and advancements in therapeutic diagnostics. The journal proudly holds a Q1 ranking in both Medicine (Miscellaneous) and Pharmacology, Toxicology and Pharmaceutics, as of 2023, showcasing its esteemed position within the scientific community. Recognized globally, it ranks in the top 1%, with Scopus rankings placing it as 4th out of 398 in Medicine and 1st out of 43 in Pharmacology. Theranostics serves as a crucial platform for researchers, professionals, and students to explore cutting-edge developments as it converges multidisciplinary approaches to enhance patient care and treatment efficacy. With a focus on bridging experimental research and clinical applications, the journal is instrumental in shaping future therapies and diagnostic strategies.

Advanced Pharmaceutical Bulletin

Pioneering Research for Tomorrow's Health Solutions
Publisher: TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICESISSN: 2228-5881Frequency: 2 issues/year

Advanced Pharmaceutical Bulletin, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, serves as a pivotal platform for disseminating groundbreaking research in the field of pharmaceutical sciences. Since its inception in 2011, this open-access journal has dedicated itself to advancing knowledge in pharmacology, toxicology, and pharmaceutics, boasting an impressive Q1 ranking in miscellaneous categories and Q2 in pharmaceutical science as of 2023. The journal is noted for its rigorous peer-review process, ensuring that published work meets the highest standards of scientific inquiry. With notable rankings, including 7th out of 80 in general pharmacology and toxicology, it sits in the 91st percentile, highlighting its significance in the research community. Researchers and practitioners alike can access cutting-edge findings and innovative methodologies, promoting collaboration and knowledge within the scientific community. Based in Tabriz, Iran, the journal remains committed to fostering research excellence, making it an invaluable resource for scholars and professionals eager to contribute to the dynamic field of pharmaceuticals.

Pharmaceutics

Fostering collaboration in the world of pharmaceutical sciences.
Publisher: MDPIISSN: Frequency: 12 issues/year

Pharmaceutics is a prestigious journal published by MDPI, specializing in the field of pharmaceutical sciences. With its Open Access model established in 2010, it promotes the dissemination of cutting-edge research, catering to a global audience of researchers, professionals, and students alike. Based in Switzerland, the journal has rapidly gained recognition, currently holding an impressive Q1 ranking in the pharmaceutical science category for 2023 and achieving a Scopus ranking of #32 out of 183 in the domain of Pharmacology, Toxicology, and Pharmaceutics, placing it in the 82nd percentile. The journal's objectives include advancing knowledge in drug formulation, delivery systems, and therapeutic applications, ensuring that published works contribute significantly to both academic discourse and practical applications in the pharmaceutical industry. As part of its commitment to excellence, Pharmaceutics welcomes high-quality manuscripts that inspire innovation and foster collaboration in this vital field.

ADVANCED DRUG DELIVERY REVIEWS

Leading the Charge in Pharmaceutical Advancements.
Publisher: ELSEVIERISSN: 0169-409XFrequency: 12 issues/year

ADVANCED DRUG DELIVERY REVIEWS, published by ELSEVIER, is a leading journal in the field of pharmaceutical sciences, particularly acclaimed for its contributions to the disciplines of pharmacology, toxicology, and pharmaceutics. With an impressive 2023 Scopus rank of #1 out of 183 in its category, this journal is situated in the Q1 quartile, reflecting its high impact and the relevance of its published research. Since its inception in 1987, it has continually focused on the latest advancements in drug delivery systems, making it an indispensable resource for researchers, professionals, and students interested in the innovative developments that shape the pharmaceutical landscape. The journal aims to publish comprehensive and authoritative reviews that foster a deeper understanding of drug delivery mechanisms, technologies, and their clinical applications. Although it operates under a subscription model, the value it provides through rigorous peer-reviewed content ensures it remains an essential tool for anyone seeking to enhance their knowledge in this rapidly evolving field.

JOURNAL OF PHARMACEUTICAL SCIENCES

Elevating research standards in the realm of pharmaceutics.
Publisher: ELSEVIER SCIENCE INCISSN: 0022-3549Frequency: 12 issues/year

The JOURNAL OF PHARMACEUTICAL SCIENCES, published by ELSEVIER SCIENCE INC, stands as a cornerstone in the field of pharmaceutical sciences, offering a platform for innovative research and advancements since its inception in 1961. With an impressive Scopus Rank of #36 out of 183 in the Pharmaceutical Science category, this journal is recognized for its commitment to disseminating high-quality, peer-reviewed studies that significantly contribute to the realms of pharmacology, toxicology, and pharmaceutics. Holding a 2023 Q2 category quartile, it attracts a diverse readership encompassing researchers, industry professionals, and students eager to advance their understanding and expertise. While the journal is not open access, it ensures valuable insights in every issue, making it an essential resource for those dedicated to the evolving landscape of pharmaceutical research. With an impact factor that reflects its relevance and influence, the JOURNAL OF PHARMACEUTICAL SCIENCES continues to shape the discourse in its domain, fostering innovation and collaboration among scholars worldwide.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Exploring the Frontiers of Drug Development
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1389-2010Frequency: 15 issues/year

CURRENT PHARMACEUTICAL BIOTECHNOLOGY is a prestigious academic journal dedicated to advancing the field of pharmaceutical biotechnology by publishing high-quality research articles, reviews, and innovatory methodologies. Published by Bentham Science Publishers Ltd, this journal has established a strong reputation in its field, reflected in its 2023 Scopus rankings: it holds an impressive Q2 classification in Pharmaceutical Science and Q3 in Biotechnology, indicating its significant impact within these disciplines. With an ISSN of 1389-2010 and an E-ISSN of 1873-4316, CURRENT PHARMACEUTICAL BIOTECHNOLOGY provides a reliable platform for disseminating valuable research findings and fostering collaboration among researchers, professionals, and students alike. The journal covers a wide array of topics, from drug development and delivery systems to innovative biotechnological techniques, thus serving as an essential resource for anyone interested in the cross-section of pharmaceutical science and biotechnology. Researchers can access a diverse range of articles that explore both theoretical frameworks and practical applications, reflecting the ongoing evolution and challenges in this dynamic field.

International Journal of Pharmaceutics-X

Empowering researchers to shape the future of pharmaceuticals.
Publisher: ELSEVIERISSN: Frequency: 1 issue/year

International Journal of Pharmaceutics-X is a premier open access journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmaceutical sciences. Launched in 2019, this journal has quickly ascended to the Q1 category in the 2023 Category Quartiles, reflecting its high impact and the quality of research it promotes. With a current Scopus ranking of #49 out of 183 in the Pharmacology, Toxicology and Pharmaceutics category, this journal occupies the 73rd percentile, showcasing its significant influence within the scholarly community. Emphasizing innovative research and novel applications, the International Journal of Pharmaceutics-X offers a platform for researchers, professionals, and students to disseminate their findings, making crucial contributions to the global pharmaceutical landscape. The journal is based in the Netherlands, presenting a vibrant hub for scientific discourse and collaboration in a rapidly evolving field.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Transforming Pharmaceutical Science Through Innovation
Publisher: ELSEVIERISSN: 1773-2247Frequency: 6 issues/year

The Journal of Drug Delivery Science and Technology, published by Elsevier, stands at the forefront of pharmaceutical research, focusing on innovative drug delivery systems and technologies. With a robust impact factor reflected in its Q1 rating within the pharmaceutical sciences category, this journal is recognized for its high-quality contributions, ranking #30 out of 183 in the Scopus pharmacology and toxicology category (2023). Since its inception in 2004, the journal has been pivotal in disseminating groundbreaking research and advancements in drug formulation and delivery methodologies. Researchers and practitioners alike benefit from its comprehensive articles, which are accessible under open access options, ensuring widespread dissemination of knowledge. As it converges towards its 20th anniversary in 2024, the journal continues to enhance its impact on the scientific community, paving the way for future innovations in drug delivery.